Abstract
We previously reported that the TRAIL (tumor necrosis factor (TNF)-related apoptosis-inducing ligand)-induced death signal requires amplification by mitochondria in certain cell types, for example, in type II cells. Here, we provide for the first time evidence that the natural compound betulinic acid (BetA) cooperated with TRAIL to induce apoptosis in tumor cells. Through functional complementation, simultaneous stimulation of the death receptor pathway by TRAIL and the mitochondrial pathway by BetA resulted in complete activation of effector caspases, apoptosis and inhibition of clonogenic survival. BetA and TRAIL cooperated to trigger loss of mitochondrial membrane potential and release of cytochrome c and Smac from mitochondria. Also, combination treatment with BetA and TRAIL resulted in increased cleavage of caspase-8 and Bid indicating that activation of effector caspases may feed back in a positive amplification loop. Importantly, the combination treatment with BetA and TRAIL cooperated to induce apoptosis in different tumor cell lines and also in primary tumor cells, but not in normal human fibroblasts indicating some tumor specificity. Since most human cancers represent type II cells, triggering the mitochondrial pathway by BetA may be a novel approach to enhance the efficacy of TRAIL-based therapies, which warrants further investigation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- AIF:
-
apoptosis-inducing factor
- BetA:
-
betulinic acid
- FACS:
-
fluorescence-activated cell sorting
- FADD:
-
Fas-associated death domain
- IAPs:
-
inhibitor of apoptosis proteins
- Smac:
-
second mitochondria-derived activator of caspase
- TNF:
-
tumor necrosis factor
- TRAIL:
-
TNF-related apoptosis-inducing ligand
- XIAP:
-
X-linked inhibitor of apoptosis
- zVAD.fmk:
-
benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone
References
Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL and Peter ME . (2003). Proc. Natl. Acad. Sci, 100, 11445–11450.
Ashkenazi A . (2002). Nat. Rev. Cancer, 2, 420–430.
Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K and Budach W . (2001). Oncogene, 20, 2190–2196.
Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD and Rehemtulla A . (2000). Proc. Natl. Acad. Sci., 97, 1754–1759.
Debatin KM, Poncet D and Kroemer G . (2002). Oncogene, 21, 8786–8803.
Fulda S and Debatin KM . (2004). Cancer Res., 64, 337–346.
Fulda S, Friesen C and Debatin KM . (1998a). Klin. Pad., 210, 148–152.
Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME and Debatin KM . (1997). Cancer Res., 57, 4956–4964.
Fulda S, Meyer E and Debatin KM . (2002). Oncogene, 21, 2283–2294.
Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME and Debatin KM . (1998b). J. Biol. Chem., 273, 33942–33948.
Gliniak B and Le T . (1999). Cancer Res., 59, 6153–6158.
Hengartner MO . (2000). Nature, 407, 770–776.
Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC . (2000). Nat. Med., 6, 564–567.
Johnstone RW, Ruefli AA and Lowe SW . (2002). Cell, 108, 153–164.
Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Banerjee P, Nau MM and Lipkowitz S . (2000). Breast Cancer Res. Treat., 64, 211–219.
Kim B and Feldman EL . (2002). J. Biol. Chem., 277, 27393–27400.
LeBlanc HN and Ashkenazi A . (2003). Cell Death Differ., 10, 66–75.
Lowe SW and Lin AW . (2000). Carcinogenesis, 21, 485–495.
Meng RD and El-Deiry WS . (2001). Exp. Cell Res., 262, 154–169.
Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK and Huang HJ . (2000). Cancer Res., 60, 847–853.
Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U and Zipp F . (2000). Lancet, 356, 827–828.
Peto J . (2001). Nature, 411, 390–395.
Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown DM and Pezzuto JM . (1995). Nat. Med., 1, 1046–1051.
Rohn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H and Weller M . (2001). Oncogene, 20, 4128–4137.
Scaffidi C, Fulda S, Debatin KM, Krammer PK and Peter ME . (1998). EMBO J., 17, 1675–1687.
Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B and Kodym R . (2000). J. Invest. Dermatol., 114, 935–940.
Stahnke K, Eckhoff S, Mohr A, Meyer LH and Debatin KM . (2003). Leukemia, 17, 2130–2139.
Takimoto R and El-Deiry WS . (2000). Oncogene, 19, 1735–1743.
van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P . (2002). Cell Death Differ., 9, 1031–1042.
Zhang HG, Wang J, Yang X, Hsu HC and Mountz JD . (2004). Oncogene, 23, 2009–2015.
Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C and Formelli F . (2002). Cancer Lett., 175, 17–25.
Acknowledgements
We thank PH Krammer (Heidelberg, Germany) for anti-caspase-8 antibody and Petra Miller-Rostek for expert technical assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Krebshilfe, the Bundesministerium für Forschung und Technologie, the Ministry of Science, Research and Arts of Baden-Württemberg, IZKF Ulm, Wilhelm-Sander-Stiftung, Else-Kröner-Stiftung, the Deutsche Kinderkrebsstiftung and the European community (to KMD and S F).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Fulda, S., Jeremias, I. & Debatin, KM. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23, 7611–7620 (2004). https://doi.org/10.1038/sj.onc.1207970
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207970
Keywords
This article is cited by
-
Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells
Journal of Translational Medicine (2009)
-
Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells
Apoptosis (2006)
-
Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy
Oncogene (2005)